Company
AVEO Oncology
Advancing Cancer Treatment Innovation
Also known as AVEO Pharmaceuticals, Inc
- Business model
- B2B
- Legal name
- AVEO Pharmaceuticals, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
AVEO Oncology develops and commercializes targeted cancer therapies, advancing innovative oncology treatments through research to improve patient outcomes.
Funding snapshot
- Total raised
- $98.2MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $7.5M2011-05-31
Funding rounds
- Round, 2011
- $7.5M2011-05-31, SEC form D sold, 1 investor
- Round, 2010
- $60.8M2010-11-03, SEC form D sold, 21 investors
- Round, 2009
- $30M2009-03-18, SEC form D sold, 1 investor
Loading relationship preview